Patient-Derived iPSC Neuronal Models Reveal Alzheimer’s Disease-Associated Pathology and Provide a Platform for Drug Discovery (SfN 2025)
Modeling ALS Using Patient-Derived iPSCs: A Human-Relevant Platform for Disease Research and Therapeutic Discovery (SfN 2025)
A Functional In Vitro Model of iPSC-Derived Oligodendrocytes for Studying Myelination and Demyelinating Diseases (SfN 2025)
Electrophysiological assay system based on iPSC-derived astrocytes generated by a rapid differentiation method (SFN 2024)
Epilepsy in a dish (EIDA): a suite of assays to discover therapeutics of epilepsy using isogenic hiPSC-neuron/astrocyte/microglia 2D and 3D tri-cultures and kinetic imaging cytometry (Society for Neuroscience 2023, Vala Sciences)
In vitro Model of Alzheimer’s Disease based on Neurons and Astrocytes Generated from Patient iPSCs using Transcription Factor-Based Rapid Differentiation Technology (Society for Neuroscience 2023)
In vitro Rett syndrome model based on MeCP2 knockdown in iPSC-derived neurons (Society for Neuroscience 2023)
Late-stage neuronal development and synaptic maturation of iPSC-derived excitatory neurons (Society for Neuroscience 2023)
Rapid Differentiation of Functional Microglia from Human iPSCs by Transduction of Transcription Factors Using Sendai Virus (Society for Neuroscience 2023)
Separation of drug effects in human iPS cell-derived neurons using MEA system (Society for Neuroscience 2019)
Characterization of iPSC-derived Skeletal Muscle Generated with Rapid Differentiation Method (Japan Muscle Society 2021)
No results found.